follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Celsion announces $15M direct offering

By

Back to Top Comments Print

Latest News

advertisement

Lawrenceville-based biopharmaceutical company Celsion Corporation announced Wednesday that it has received commitments from investors to purchase approximately $15 million in common stock in an at-the-market registered direct offering led by a dedicated health care fund.

According to the announcement, Celsion entered into definitive purchase agreements with the investors to sell 3.6 million shares of common stock at a per-share price of $4.16. The closing of the offering is expected to take place around January 21.

The estimated net profit to the company from the offering are expected to be approximately $13.8 million. The announcement said H.C. Wainwright & Co., LLC acted as exclusive placement agent in connection with the offering, Celsion said in a statement.


Like us on Facebook: facebook.com/NJBIZ

Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at emilyb@njbiz.com or @emilybader on Twitter.

advertisement

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top